FDA Agrees to Remove Anti-Ivermectin Content

The U.S. Food and Drug Administration (FDA) has agreed to remove social media posts that told people not to use Ivermectin to treat COVID-19.

The settlement calls for the FDA to “delete and not republish” several posts warning against the drug.

One page against Ivermectin has already been removed, with another, titled, “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19,” to be removed within 21 days.

“FDA loses its war on ivermectin and agrees to remove all social media posts and consumer directives regarding ivermectin and COVID, including its most popular tweet in FDA history,” Dr. Mary Talley Bowden said in a statement. “This landmark case sets an important precedent in limiting FDA overreach into the doctor-patient relationship.”

“Today’s settlement with the FDA is a major win for the doctor-patient relationship,” Dr. Paul Marik, said. “It vindicates our position that the FDA overstepped its regulatory authority by trying to dictate appropriate medical care.”

A recent U.K. study found that COVID-19 patients who were given ivermectin recovered faster than those who were not given the drug. Patients receiving ivermectin were also less likely to be hospitalized or die. Only 1.6% of patients on ivermectin were hospitalized, compared to 4.4% of those receiving usual care.

Despite patients recovering faster on the antiparasitic drug, the authors concluded that “ivermectin should not be used to treat SARS-Cov-2 infection in the community in high-income countries with a largely vaccinated population.”